Advanced search
Publication Cover
Journal of Blood Medicine Volume 12, 2021 - Issue
Submit an article Journal homepage
137
Views
8
CrossRef citations to date
0
Altmetric
Case Report

A Case Report of COVID-Associated Catastrophic Antiphospholipid Syndrome Successfully Treated with Eculizumab

Anusha Chidharla1 Department of Medical Oncology, Kansas University Cancer Center, Kansas, KS, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8611-8875
ORCID Icon,
Salman B Syed2 Department of Internal Medicine, University of Illinois College of Medicine, Peoria, IL, USAORCID Iconhttps://orcid.org/0000-0003-4478-7813
ORCID Icon,
Tulika Chatterjee2 Department of Internal Medicine, University of Illinois College of Medicine, Peoria, IL, USA
&
Michael D Tarantino3 Department of Hematology, Bleeding and Clotting Disorders Institute, Peoria, IL, USA
Pages 929-933 | Published online: 30 Oct 2021

References

  • Gezer S. Antiphospholipid syndrome. Dis Mon. 2003;49(12):696–741. doi:10.1016/j.disamonth.2003.10.001
  • Rodriguez-Pintó I, López-Benjume B, Espinosa G, Cervera R. Catastrophic antiphospholipid syndrome. Rev Colomb De Reumatol. 2021;28:39–43. doi:10.1016/j.rcreu.2021.02.004
  • Chaturvedi S, Braunstein EM, Yuan X, et al. Rare Germline mutations in complement regulatory genes make the antiphospholipid syndrome catastrophic. Blood. 2019;134(Supplement_1):4. doi:10.1182/blood-2019-129115
  • Rodríguez-Pintó I, Moitinho M, Santacreu I, et al. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the International CAPS registry. Autoimmun Rev. 2016;15(12):1120–1124. doi:10.1016/j.autrev.2016.09.010
  • Xiao M, Zhang Y, Zhang S, et al. Antiphospholipid antibodies in critically ill patients with COVID-19. Arthritis Rheumatol. 2020;72(12):1998–2004. doi:10.1002/art.41425
  • El Hasbani G, Taher AT, Jawad A, Uthman I. COVID-19, antiphospholipid antibodies, and catastrophic antiphospholipid syndrome: a possible association? Clin Med Insights Arthritis Musculoskelet Disord. 2020;13:1179544120978667. doi:10.1177/1179544120978667
  • Mendoza-Pinto C, García-Carrasco M, Cervera R. Role of infectious diseases in the antiphospholipid syndrome (including its catastrophic variant). Curr Rheumatol Rep. 2018;20(10):62. doi:10.1007/s11926-018-0773-x
  • Merrill JT, Erkan D, Winakur J, James JA. Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications. Nat Rev Rheumatol. 2020;16(10):581–589. doi:10.1038/s41584-020-0474-5
  • Mendoza-Pinto C, Escárcega RO, García-Carrasco M, Bailey DJO, Gálvez-Romero JL, Cervera R. Viral infections and their relationship with catastrophic antiphospholipid syndrome: a possible pathogenic mechanism of severe COVID-19 thrombotic complications. J Intern Med. 2020;288(6):737–739. doi:10.1111/joim.13123
  • Upson S, Murphy M, Ashraf F, Shahzad S. Double trouble: a case of suspected antiphospholipid syndrome in the setting of hypercoagulable COVID-19 pneumonia. Chest. 2020;158(4):A862. doi:10.1016/j.chest.2020.08.801
  • Yin S, Huang M, Li D, Tang N. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2. J Thromb Thrombolysis. 2020. doi:10.1007/s11239-020-02105-8
  • Gansner JM, Berliner N. The rheumatology/hematology interface: CAPS and MAS diagnosis and management. Hematology. 2018;2018(1):313–317. doi:10.1182/asheducation-2018.1.313
  • Rymarz A, Niemczyk S. The complex treatment including rituximab in the management of catastrophic antiphospholid syndrome with renal involvement. BMC Nephrol. 2018;19(1):132. doi:10.1186/s12882-018-0928-z
  • Kazzaz NM, McCune WJ, Knight JS. Treatment of catastrophic antiphospholipid syndrome. Curr Opin Rheumatol. 2016;28(3):218–227. doi:10.1097/BOR.0000000000000269
  • Tinti MG, Carnevale V, Inglese M, et al. Eculizumab in refractory catastrophic antiphospholipid syndrome: a case report and systematic review of the literature. Clin Exp Med. 2019;19(3):281–288. doi:10.1007/s10238-019-00565-8
  • Nauseef JT, Lim HI, DeSancho MT. Successful outcome with eculizumab treatment in a patient with antiphospholipid syndrome presenting with an unusual thrombotic storm. J Thromb Thrombolysis. 2020. doi:10.1007/s11239-020-02343-w
  • Yelnik CM, Miranda S, Mékinian A, et al. Patients with refractory catastrophic antiphospholipid syndrome respond inconsistently to eculizumab. Blood. 2020;136(21):2473–2477. doi:10.1182/blood.2020007499
  • Fodil S, Annane D. Complement inhibition and COVID-19: the story so far. ImmunoTargets Ther. 2021;10:273–284. doi:10.2147/ITT.S284830

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.